건양대학교병원은 대전광역시 서구에 있는 건양대학교 부속 종합병원이다.

During the past decade, Konyang University Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 4 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Konyang University Hospital" #1 sponsor was "Seung-Jung Park" with 3 trials, followed by "Ajou University School of Medicine" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Chong Kun Dang Pharmaceutical" with 2 trials sponsored and "Daiichi Sankyo, Inc." with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Konyang University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator, "Daiichi Sankyo Korea Co., Ltd." with 2 trials as a collaborator, "Konyang University Hospital" with 2 trials as a collaborator, "Kyunghee University Medical Center" with 2 trials as a collaborator and "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Konyang University Hospital" are "Coronary Artery Disease" (5 trials), "Crohn Disease" (2 trials), "Dyslipidemia" (2 trials), "Essential Hypertension" (2 trials) and "Hepatocellular Carcinoma" (2 trials). Many other conditions were trialed in "Konyang University Hospital" in a lesser frequency.

Most popular intervention types in "Konyang University Hospital" are "Drug" (29 trials), "Device" (5 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Capecitabine" (2 trials), "5-fluorouracil" (1 trials), "Abilify maintena" (1 trials) and "Alcaftadine Ophthalmic Solution 0.25%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Konyang University Hospital" are 40 trials for "All" genders.

Currently, there are NaN active trials in "Konyang University Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Konyang University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Konyang University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".